Newman T, Bond D, Ishihara T, Rizzoli P, Gouil Q, Hore T
Epigenetics Chromatin. 2024; 17(1):29.
PMID: 39342354
PMC: 11438212.
DOI: 10.1186/s13072-024-00552-8.
Prawitt D, Eggermann T
Front Genet. 2024; 15:1382371.
PMID: 38894719
PMC: 11183334.
DOI: 10.3389/fgene.2024.1382371.
DOcchio M, Campanile G, Baruselli P, Porto Neto L, Hayes B, Snr A
J Anim Sci. 2024; 102.
PMID: 38586898
PMC: 11056886.
DOI: 10.1093/jas/skae103.
Kardian A, Mack S
Dev Neurosci. 2024; 46(6):365-372.
PMID: 38527429
PMC: 11614414.
DOI: 10.1159/000537694.
Eggermann T
Genes (Basel). 2024; 15(2).
PMID: 38397153
PMC: 10888310.
DOI: 10.3390/genes15020163.
Imprinted Long Non-Coding RNAs in Mammalian Development and Disease.
Di Michele F, Chillon I, Feil R
Int J Mol Sci. 2023; 24(17).
PMID: 37686455
PMC: 10487962.
DOI: 10.3390/ijms241713647.
Co-occurrence of Beckwith-Wiedemann syndrome and pseudohypoparathyroidism type 1B: coincidence or common molecular mechanism?.
Pignata L, Cecere F, Acquaviva F, DAngelo E, Cioffi D, Pellino V
Front Cell Dev Biol. 2023; 11:1237629.
PMID: 37635873
PMC: 10448386.
DOI: 10.3389/fcell.2023.1237629.
Imprinted dosage as a size determinant of the mammalian pituitary gland.
Scagliotti V, Vignola M, Willis T, Howard M, Marinelli E, Gaston-Massuet C
Elife. 2023; 12.
PMID: 37589451
PMC: 10468206.
DOI: 10.7554/eLife.84092.
Imprinting disorders.
Eggermann T, Monk D, Perez de Nanclares G, Kagami M, Giabicani E, Riccio A
Nat Rev Dis Primers. 2023; 9(1):33.
PMID: 37386011
DOI: 10.1038/s41572-023-00443-4.
Modeling human skeletal development using human pluripotent stem cells.
Lamande S, Ng E, Cameron T, Kung L, Sampurno L, Rowley L
Proc Natl Acad Sci U S A. 2023; 120(19):e2211510120.
PMID: 37126720
PMC: 10175848.
DOI: 10.1073/pnas.2211510120.
Long non-coding RNA H19: a potential biomarker and therapeutic target in human malignant tumors.
Zhang R, Zeng Y, Deng J
Clin Exp Med. 2022; 23(5):1425-1440.
PMID: 36484927
DOI: 10.1007/s10238-022-00947-5.
Increased copy number of imprinted genes in the chromosomal region 20q11-q13.32 is associated with resistance to antitumor agents in cancer cell lines.
Krushkal J, Vural S, Jensen T, Wright G, Zhao Y
Clin Epigenetics. 2022; 14(1):161.
PMID: 36461044
PMC: 9716673.
DOI: 10.1186/s13148-022-01368-7.
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
Keck M, Sill M, Wittmann A, Joshi P, Stichel D, Beck P
Acta Neuropathol. 2022; 145(1):49-69.
PMID: 36437415
PMC: 9807491.
DOI: 10.1007/s00401-022-02516-2.
Systematic investigation of imprinted gene expression and enrichment in the mouse brain explored at single-cell resolution.
Higgs M, Hill M, John R, Isles A
BMC Genomics. 2022; 23(1):754.
PMID: 36384442
PMC: 9670596.
DOI: 10.1186/s12864-022-08986-8.
The imprinted gene Zac1 regulates steatosis in developmental cadmium-induced nonalcoholic fatty liver disease.
Riegl S, Starnes C, Jima D, Baptissart M, Diehl A, Belcher S
Toxicol Sci. 2022; 191(1):34-46.
PMID: 36200916
PMC: 9887675.
DOI: 10.1093/toxsci/kfac106.
Molecular Basis of Beckwith-Wiedemann Syndrome Spectrum with Associated Tumors and Consequences for Clinical Practice.
Eggermann T, Maher E, Kratz C, Prawitt D
Cancers (Basel). 2022; 14(13).
PMID: 35804856
PMC: 9265096.
DOI: 10.3390/cancers14133083.
: Development, Genetic and Epigenetic Abnormalities.
Selenou C, Brioude F, Giabicani E, Sobrier M, Netchine I
Cells. 2022; 11(12).
PMID: 35741015
PMC: 9221339.
DOI: 10.3390/cells11121886.
Genomic Imprinting in the New Omics Era: A Model for Systems-Level Approaches.
Hubert J, Demars J
Front Genet. 2022; 13:838534.
PMID: 35368671
PMC: 8965095.
DOI: 10.3389/fgene.2022.838534.
Trans-acting genetic variants causing multilocus imprinting disturbance (MLID): common mechanisms and consequences.
Eggermann T, Yapici E, Bliek J, Pereda A, Begemann M, Russo S
Clin Epigenetics. 2022; 14(1):41.
PMID: 35296332
PMC: 8928698.
DOI: 10.1186/s13148-022-01259-x.
Epigenetic Dysregulation of Imprinting and Triple-Negative Breast Cancer.
Skaar D, Dietze E, Alva-Ornelas J, Ann D, Schones D, Hyslop T
Cancers (Basel). 2021; 13(23).
PMID: 34885139
PMC: 8656495.
DOI: 10.3390/cancers13236031.